Key result
Higher BMI linked to ~5% lower mortality in HF without diabetes, but not with diabetes.
Why the study?
The influence of comorbid diabetes on the relationship between obesity and survival in patients with heart failure is unclear.
Does higher body mass index improve survival in ambulatory heart failure patients with and without comorbid diabetes?
Observational (n=560)
Does higher body mass index improve survival in ambulatory heart failure patients with and without comorbid diabetes?
Hazard Ratio: 0.952 (95% CI 0.909–0.998)
The obesity paradox in heart failure, where higher body mass index confers a survival benefit, appears to be present only in patients without comorbid diabetes.
Obesity may confer survival benefit in HF only without diabetes; leaves open whether diabetes modifies the obesity paradox.
BACKGROUND: Diabetes is a common comorbid condition in patients with heart failure and is strongly associated with poor outcomes. Patients with heart failure who have diabetes are more likely to be obese than are those without diabetes. Obesity is positively associated with survival in patients with heart failure, but how comorbid diabetes influences the relationship between obesity and favorable prognosis is unclear. OBJECTIVE: To explore whether the relationship between body mass index and survival differs between patients with heart failure who do or do not have diabetes. METHODS: The sample consisted of 560 ambulatory patients with heart failure (mean age, 66 years; mean body mass index, 32; diabetes, 41%). The association between body mass index and all-cause mortality was examined by using multivariate Cox proportional hazards regression after adjustments for covariates. RESULTS: In patients without diabetes, higher body mass index was associated with a lower risk for all-cause mortality after adjustments for covariates (hazard ratio, 0.952; 95% CI, 0.909-0.998). In patients with diabetes, body mass index was not predictive of all-cause death after adjustments for covariates. CONCLUSION: Obesity was a survival benefit in heart failure patients without comorbid diabetes but not in those with comorbid diabetes. The mechanisms underlying the difference in the relationship between obesity and survival due to the presence of diabetes in patients with heart failure need to be elucidated.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2017) conducted an observational in Heart failure (n=560). Higher body mass index vs. Lower body mass index was evaluated on All-cause mortality (HR 0.952, 95% CI 0.909-0.998). Higher body mass index was associated with a lower risk of all-cause mortality in heart failure patients without diabetes (HR 0.952; 95% CI 0.909-0.998), but not in those with comorbid diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: